πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 167 of 200 Β· A–Z by INN

  1. sim0417 600 mg; ritonavir100 mg

    NMPA: clinical trials

  2. sim0417 750 mg; ritonavir100 mg

    NMPA: clinical trials

  3. sim0500

    NMPA: clinical trials

  4. sim1803-1a

    NMPA: clinical trials

  5. simeprevir

    OLYSIO

    EMA: withdrawn

    J05AE14
  6. simeprevir sodium

    SOVRIAD

    ORAL FDA: approved Β· PMDA: approved

  7. simethicone-cellulose

    SONORX

    ORAL FDA: approved

  8. simmitinib

    NMPA: clinical trials

  9. simoctocog alfa

    NUWIQ

    EMA: approved

    B02BD02
  10. simple ointment (white) (for use only as a base combined with active ingredients)

    NULL

    TGA: approved

  11. simple ointment (yellow) (for use only as a base combined with active ingredients)

    NULL

    TGA: approved

  12. simultaneous

    NMPA: clinical trials

  13. simvastatin

    APO-SIMVASTATIN Alphapharm Pty Ltd

    ORAL FDA: approved Β· TGA: approved Β· NMPA: clinical trials

  14. sinapultide

    SURFAXIN

    EMA: application withdrawn

  15. sincalide

    SINCALIDE MAIA Biotechnology

    INTRAVENOUS FDA: approved

  16. sinecatechins

    VEREGEN

    TOPICAL FDA: approved

  17. sintilimab

    NMPA: clinical trials

  18. sipavibart

    KAVIGALE

    EMA: approved Β· PMDA: approved

    J06BD09
  19. siponimod

    MAYZENT Novartis Pharmaceuticals

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L04
  20. siponimod fumaric acid

    MAYZENT

    PMDA: approved

  21. sirolimus

    RAPAMUNE Pfizer Australia Pty Ltd

    TOPICAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L04AH01
  22. sirukumab

    PLIVENSIA

    EMA: application withdrawn

    L04AC
  23. sitagliptin

    JANUVIA Alphapharm Pty Ltd

    FILM COATED FDA: approved Β· EMA: approved Β· TGA: approved

    A10BH01
  24. sitagliptin + metformin

    JANUMET XR Alphapharm Pty Ltd

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources